443 related articles for article (PubMed ID: 11588023)
1. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells.
Guzman ML; Neering SJ; Upchurch D; Grimes B; Howard DS; Rizzieri DA; Luger SM; Jordan CT
Blood; 2001 Oct; 98(8):2301-7. PubMed ID: 11588023
[TBL] [Abstract][Full Text] [Related]
2. Preferential induction of apoptosis for primary human leukemic stem cells.
Guzman ML; Swiderski CF; Howard DS; Grimes BA; Rossi RM; Szilvassy SJ; Jordan CT
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16220-5. PubMed ID: 12451177
[TBL] [Abstract][Full Text] [Related]
3. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.
Bosman MC; Schuringa JJ; Quax WJ; Vellenga E
Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210
[TBL] [Abstract][Full Text] [Related]
5. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
6. ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia.
Raaijmakers MH; de Grouw EP; van der Reijden BA; de Witte TJ; Jansen JH; Raymakers RA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3452-8. PubMed ID: 16740770
[TBL] [Abstract][Full Text] [Related]
7. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.
Jordan CT; Upchurch D; Szilvassy SJ; Guzman ML; Howard DS; Pettigrew AL; Meyerrose T; Rossi R; Grimes B; Rizzieri DA; Luger SM; Phillips GL
Leukemia; 2000 Oct; 14(10):1777-84. PubMed ID: 11021753
[TBL] [Abstract][Full Text] [Related]
8. Leukemia stem cells and constitutive activation of NF-kappaB.
Griffin JD
Blood; 2001 Oct; 98(8):2291. PubMed ID: 11588020
[No Abstract] [Full Text] [Related]
9. Increased levels of NOTCH1, NF-kappaB, and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells.
Panepucci RA; Oliveira LH; Zanette DL; Viu Carrara Rde C; Araujo AG; Orellana MD; Bonini de Palma PV; Menezes CC; Covas DT; Zago MA
Stem Cells Dev; 2010 Mar; 19(3):321-32. PubMed ID: 19686049
[TBL] [Abstract][Full Text] [Related]
10. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
[TBL] [Abstract][Full Text] [Related]
11. Phenotyping and Target Expression Profiling of CD34
Blatt K; Menzl I; Eisenwort G; Cerny-Reiterer S; Herrmann H; Herndlhofer S; Stefanzl G; Sadovnik I; Berger D; Keller A; Hauswirth A; Hoermann G; Willmann M; Rülicke T; Sill H; Sperr WR; Mannhalter C; Melo JV; Jäger U; Sexl V; Valent P
Neoplasia; 2018 Jun; 20(6):632-642. PubMed ID: 29772458
[TBL] [Abstract][Full Text] [Related]
12. Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.
Moshaver B; Wouters RF; Kelder A; Ossenkoppele GJ; Westra GAH; Kwidama Z; Rutten AR; Kaspers GJL; Zweegman S; Cloos J; Schuurhuis GJ
Leuk Res; 2019 Jun; 81():27-34. PubMed ID: 31002948
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2.
Xu B; Wang S; Li R; Chen K; He L; Deng M; Kannappan V; Zha J; Dong H; Wang W
Cell Death Dis; 2017 May; 8(5):e2797. PubMed ID: 28518151
[TBL] [Abstract][Full Text] [Related]
14. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.
Bernstein ID; Singer JW; Smith FO; Andrews RG; Flowers DA; Petersens J; Steinmann L; Najfeld V; Savage D; Fruchtman S
Blood; 1992 Apr; 79(7):1811-6. PubMed ID: 1373089
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
16. Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.
Volk A; Li J; Xin J; You D; Zhang J; Liu X; Xiao Y; Breslin P; Li Z; Wei W; Schmidt R; Li X; Zhang Z; Kuo PC; Nand S; Zhang J; Chen J; Zhang J
J Exp Med; 2014 Jun; 211(6):1093-108. PubMed ID: 24842373
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells.
Guzman ML; Upchurch D; Grimes B; Howard DS; Rizzieri DA; Luger SM; Phillips GL; Jordan CT
Blood; 2001 Apr; 97(7):2177-9. PubMed ID: 11264190
[TBL] [Abstract][Full Text] [Related]
18. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
[TBL] [Abstract][Full Text] [Related]
19. Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia.
George AA; Franklin J; Kerkof K; Shah AJ; Price M; Tsark E; Bockstoce D; Yao D; Hart N; Carcich S; Parkman R; Crooks GM; Weinberg K
Blood; 2001 Jun; 97(12):3925-30. PubMed ID: 11389036
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
Baersch G; Baumann M; Meltzer J; Möllers T; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
